跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-RIZATRIPTAN ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-RIZATRIPTAN ODT
Authorized
STANDARD
MAR-RIZATRIPTAN ODT
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
315627d90fe70386
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
315627d90fe70386
Drug Approval Canada Name
MAR-RIZATRIPTAN ODT
Product Name
MAR-RIZATRIPTAN ODT
Status
Marketed
Status Date
2018-02-15
Original Market Date
2018-02-15
Din
02462788
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:32.28
Atc Original
N02CC04 RIZATRIPTAN
Atc Name
n 02 cc 04
Aig Number
0137841001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
315627d90fe70386
Type
Standard
Back to Health Canada Approvals